Objective: the study aims to expose the relationship between innovation and regulatory activities through the experiences of Brazilian regulatory agencies.Methodology: the study follows a bibliographical approach, adopting bibliographical and documentary research and collecting data from academic publications, reports and information published on the Federal Government’s website.Findings: through this essay it was possible to perceive how innovation is indispensable to regulatory activities, in view of the benefits provided to agencies and, especially, the positive impacts for society.Research limitations: since this is a theoretical study, the relationship between innovation and regulatory activities was limited to the experiences shared in the researched sources. Given a certain deficit of approach to the subject in the prevailing literature, we believe that an in loco research would be a more robust source of information and, thus, other innovation actions, not shared in academic works and/or websites, would be identified.Originality/value: the study’s contributions permeate the universe of the link between innovation and regulatory agencies, demonstrating the relevance of innovative actions to ensure efficiency and effectiveness in public services, taking four Brazilian agencies as an example. The absence of research on innovation in regulatory agencies at the national level characterizes the originality of the work. It is suggested, therefore, that regulatory agencies systematize their information on innovation actions and make it available to the public, in the form of a report, presenting the results achieved and the benefits acquired.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.